Start main content

創新技術 (專利發明)

Anti-HER2 and Anti-IGF-IR Bi-specific Antibodies for Ovarian Cancers

IGF-1R is implicated in several cancers. Due to the similarity of the structures of IGF-1R and the insulin receptor (IR), especially in the regions of the ATP binding site and tyrosine kinase regions, synthesizing selective inhibitors of IGF-1R is difficult.

Therapeutic Biologics